Clinical Trial

Vaginal Estradiol and Oral Guaifenesin in Clomiphene Ovulation Induction

Study acronym: CC-OVI
Completed
View on ClinicalTrials.gov →
Summary
Clomiphene citrate is commonly used for ovulation induction; however, it may negatively affect endometrial development and cervical mucus quality, which can reduce pregnancy rates. Various adjunctive treatments have been proposed to overcome these antiestrogenic effects. This randomized clinical trial aimed to compare the effects of vaginal estradiol and oral guaifenesin, alone or in combination, on endometrial thickness, cervical mucus characteristics, and clinical pregnancy rates in women undergoing ovulation induction with clomiphene citrate. A total of 90 women with infertility undergoing ovulation induction were randomly assigned to one of three treatment groups: clomiphene citrate plus guaifenesin, clomiphene citrate plus vaginal estradiol, or clomiphene citrate combined with both guaife
Trial Details
NCT Number NCT07398924
Lead Sponsor Yuzuncu Yil University
Conditions Female Infertility, Anovulatory Infertility, Unexplained Infertility
Enrollment 90 participants
Start Date 2022-01-06
Primary Completion 2023-06-06 (estimated)
Study Completion 2023-06-23 (estimated)
Updated on ClinicalTrials.gov 2026-02-10